<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    >

   <link:roleRef xlink:type="simple" xlink:href="815600F8217BC7733697-2021-12-31.xsd#id_2" roleURI="https://www.pharmanutra.it/xbrl/role/all/ifrs-dim_role-901000"/>
   <link:roleRef xlink:type="simple" xlink:href="815600F8217BC7733697-2021-12-31.xsd#id_3" roleURI="https://www.pharmanutra.it/xbrl/role/all/ifrs-dim_role-901100"/>
   <link:roleRef xlink:type="simple" xlink:href="815600F8217BC7733697-2021-12-31.xsd#id_5" roleURI="https://www.pharmanutra.it/xbrl/role/all/ifrs-dim_role-903000"/>
   <link:roleRef xlink:type="simple" xlink:href="815600F8217BC7733697-2021-12-31.xsd#id_157" roleURI="https://www.pharmanutra.it/xbrl/role/all/esef_role-000000"/>
   <link:roleRef xlink:type="simple" xlink:href="815600F8217BC7733697-2021-12-31.xsd#id_159" roleURI="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-210000"/>
   <link:roleRef xlink:type="simple" xlink:href="815600F8217BC7733697-2021-12-31.xsd#id_160" roleURI="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-220000"/>
   <link:roleRef xlink:type="simple" xlink:href="815600F8217BC7733697-2021-12-31.xsd#id_8" roleURI="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-310000"/>
   <link:roleRef xlink:type="simple" xlink:href="815600F8217BC7733697-2021-12-31.xsd#id_9" roleURI="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-320000"/>
   <link:roleRef xlink:type="simple" xlink:href="815600F8217BC7733697-2021-12-31.xsd#id_161" roleURI="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-410000"/>
   <link:roleRef xlink:type="simple" xlink:href="815600F8217BC7733697-2021-12-31.xsd#id_162" roleURI="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-420000"/>
   <link:roleRef xlink:type="simple" xlink:href="815600F8217BC7733697-2021-12-31.xsd#id_10" roleURI="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-610000"/>
   <link:roleRef xlink:type="simple" xlink:href="815600F8217BC7733697-2021-12-31.xsd#id_174" roleURI="https://www.pharmanutra.it/xbrl/role/all/ias_26_role-710000"/>
   <link:roleRef xlink:type="simple" xlink:href="815600F8217BC7733697-2021-12-31.xsd#id_180" roleURI="https://www.pharmanutra.it/xbrl/role/all/ias_7_role-510000"/>
   <link:roleRef xlink:type="simple" xlink:href="815600F8217BC7733697-2021-12-31.xsd#id_181" roleURI="https://www.pharmanutra.it/xbrl/role/all/ias_7_role-520000"/>
   <!-- http://www.xbrl.org/2003/arcrole/parent-child https://www.pharmanutra.it/xbrl/role/all/ifrs-dim_role-901000 -->
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ifrs-dim_role-901000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RestatedMember" xlink:label="ifrs-full_RestatedMember" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis"
                          xlink:to="ifrs-full_RestatedMember"
                            order="10.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <!-- http://www.xbrl.org/2003/arcrole/parent-child https://www.pharmanutra.it/xbrl/role/all/ifrs-dim_role-901100 -->
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ifrs-dim_role-901100" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DepartureFromRequirementOfIFRSAxis" xlink:label="ifrs-full_DepartureFromRequirementOfIFRSAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RestatedMember" xlink:label="ifrs-full_RestatedMember" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_DepartureFromRequirementOfIFRSAxis"
                          xlink:to="ifrs-full_RestatedMember"
                            order="10.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <!-- http://www.xbrl.org/2003/arcrole/parent-child https://www.pharmanutra.it/xbrl/role/all/ifrs-dim_role-903000 -->
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ifrs-dim_role-903000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:label="ifrs-full_ContinuingAndDiscontinuedOperationsAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ContinuingOperationsMember" xlink:label="ifrs-full_ContinuingOperationsMember" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ContinuingAndDiscontinuedOperationsAxis"
                          xlink:to="ifrs-full_ContinuingOperationsMember"
                            order="10.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <!-- http://www.xbrl.org/2003/arcrole/parent-child https://www.pharmanutra.it/xbrl/role/all/esef_role-000000 -->
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/esef_role-000000" xlink:type="extended">
      <link:loc xlink:href="http://www.esma.europa.eu/taxonomy/2020-03-16/esef_cor.xsd#esef_cor_NotesAccountingPoliciesAndMandatoryTags" xlink:label="esef_cor_NotesAccountingPoliciesAndMandatoryTags" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NameOfReportingEntityOrOtherMeansOfIdentification" xlink:label="ifrs-full_NameOfReportingEntityOrOtherMeansOfIdentification" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="esef_cor_NotesAccountingPoliciesAndMandatoryTags"
                          xlink:to="ifrs-full_NameOfReportingEntityOrOtherMeansOfIdentification"
                            order="10.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ExplanationOfChangeInNameOfReportingEntityOrOtherMeansOfIdentificationFromEndOfPrecedingReportingPeriod" xlink:label="ifrs-full_ExplanationOfChangeInNameOfReportingEntityOrOtherMeansOfIdentificationFromEndOfPrecedingReportingPeriod" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="esef_cor_NotesAccountingPoliciesAndMandatoryTags"
                          xlink:to="ifrs-full_ExplanationOfChangeInNameOfReportingEntityOrOtherMeansOfIdentificationFromEndOfPrecedingReportingPeriod"
                            order="20.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DomicileOfEntity" xlink:label="ifrs-full_DomicileOfEntity" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="esef_cor_NotesAccountingPoliciesAndMandatoryTags"
                          xlink:to="ifrs-full_DomicileOfEntity"
                            order="30.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LegalFormOfEntity" xlink:label="ifrs-full_LegalFormOfEntity" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="esef_cor_NotesAccountingPoliciesAndMandatoryTags"
                          xlink:to="ifrs-full_LegalFormOfEntity"
                            order="40.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CountryOfIncorporation" xlink:label="ifrs-full_CountryOfIncorporation" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="esef_cor_NotesAccountingPoliciesAndMandatoryTags"
                          xlink:to="ifrs-full_CountryOfIncorporation"
                            order="50.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AddressOfRegisteredOfficeOfEntity" xlink:label="ifrs-full_AddressOfRegisteredOfficeOfEntity" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="esef_cor_NotesAccountingPoliciesAndMandatoryTags"
                          xlink:to="ifrs-full_AddressOfRegisteredOfficeOfEntity"
                            order="60.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PrincipalPlaceOfBusiness" xlink:label="ifrs-full_PrincipalPlaceOfBusiness" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="esef_cor_NotesAccountingPoliciesAndMandatoryTags"
                          xlink:to="ifrs-full_PrincipalPlaceOfBusiness"
                            order="70.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities" xlink:label="ifrs-full_DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="esef_cor_NotesAccountingPoliciesAndMandatoryTags"
                          xlink:to="ifrs-full_DescriptionOfNatureOfEntitysOperationsAndPrincipalActivities"
                            order="80.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NameOfParentEntity" xlink:label="ifrs-full_NameOfParentEntity" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="esef_cor_NotesAccountingPoliciesAndMandatoryTags"
                          xlink:to="ifrs-full_NameOfParentEntity"
                            order="90.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NameOfUltimateParentOfGroup" xlink:label="ifrs-full_NameOfUltimateParentOfGroup" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="esef_cor_NotesAccountingPoliciesAndMandatoryTags"
                          xlink:to="ifrs-full_NameOfUltimateParentOfGroup"
                            order="100.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <!-- http://www.xbrl.org/2003/arcrole/parent-child https://www.pharmanutra.it/xbrl/role/all/ias_1_role-210000 -->
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-210000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AssetsAbstract" xlink:label="ifrs-full_AssetsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="ifrs-full_NoncurrentAssetsAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_AssetsAbstract"
                          xlink:to="ifrs-full_NoncurrentAssetsAbstract"
                            order="10.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="ifrs-full_CurrentAssetsAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_AssetsAbstract"
                          xlink:to="ifrs-full_CurrentAssetsAbstract"
                            order="20.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Assets" xlink:label="ifrs-full_Assets" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_AssetsAbstract"
                          xlink:to="ifrs-full_Assets"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="30.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-210000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentAssetsAbstract" xlink:label="ifrs-full_NoncurrentAssetsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_NoncurrentAssetsAbstract"
                          xlink:to="ifrs-full_PropertyPlantAndEquipment"
                            order="10.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_NoncurrentAssetsAbstract"
                          xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill"
                            order="40.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_NoncurrentAssetsAbstract"
                          xlink:to="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates"
                            order="60.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DeferredTaxAssets" xlink:label="ifrs-full_DeferredTaxAssets" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_NoncurrentAssetsAbstract"
                          xlink:to="ifrs-full_DeferredTaxAssets"
                            order="100.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherNoncurrentFinancialAssets" xlink:label="ifrs-full_OtherNoncurrentFinancialAssets" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_NoncurrentAssetsAbstract"
                          xlink:to="ifrs-full_OtherNoncurrentFinancialAssets"
                            order="120.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherNoncurrentNonfinancialAssets" xlink:label="ifrs-full_OtherNoncurrentNonfinancialAssets" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_NoncurrentAssetsAbstract"
                          xlink:to="ifrs-full_OtherNoncurrentNonfinancialAssets"
                            order="130.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentAssets" xlink:label="ifrs-full_NoncurrentAssets" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_NoncurrentAssetsAbstract"
                          xlink:to="ifrs-full_NoncurrentAssets"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="150.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-210000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentAssetsAbstract" xlink:label="ifrs-full_CurrentAssetsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Inventories" xlink:label="ifrs-full_Inventories" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CurrentAssetsAbstract"
                          xlink:to="ifrs-full_Inventories"
                            order="10.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeAndOtherCurrentReceivables" xlink:label="ifrs-full_TradeAndOtherCurrentReceivables" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CurrentAssetsAbstract"
                          xlink:to="ifrs-full_TradeAndOtherCurrentReceivables"
                            order="20.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentTaxAssetsCurrent" xlink:label="ifrs-full_CurrentTaxAssetsCurrent" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CurrentAssetsAbstract"
                          xlink:to="ifrs-full_CurrentTaxAssetsCurrent"
                            order="30.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentFinancialAssets" xlink:label="ifrs-full_OtherCurrentFinancialAssets" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CurrentAssetsAbstract"
                          xlink:to="ifrs-full_OtherCurrentFinancialAssets"
                            order="50.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentNonfinancialAssets" xlink:label="ifrs-full_OtherCurrentNonfinancialAssets" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CurrentAssetsAbstract"
                          xlink:to="ifrs-full_OtherCurrentNonfinancialAssets"
                            order="60.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CurrentAssetsAbstract"
                          xlink:to="ifrs-full_CashAndCashEquivalents"
                            order="70.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentAssets" xlink:label="ifrs-full_CurrentAssets" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CurrentAssetsAbstract"
                          xlink:to="ifrs-full_CurrentAssets"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="120.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-210000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="ifrs-full_CurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_TradeAndOtherCurrentPayables" xlink:label="ifrs-full_TradeAndOtherCurrentPayables" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CurrentLiabilitiesAbstract"
                          xlink:to="ifrs-full_TradeAndOtherCurrentPayables"
                            order="20.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:label="ifrs-full_CurrentTaxLiabilitiesCurrent" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CurrentLiabilitiesAbstract"
                          xlink:to="ifrs-full_CurrentTaxLiabilitiesCurrent"
                            order="30.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentFinancialLiabilities" xlink:label="ifrs-full_OtherCurrentFinancialLiabilities" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CurrentLiabilitiesAbstract"
                          xlink:to="ifrs-full_OtherCurrentFinancialLiabilities"
                            order="40.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherCurrentNonfinancialLiabilities" xlink:label="ifrs-full_OtherCurrentNonfinancialLiabilities" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CurrentLiabilitiesAbstract"
                          xlink:to="ifrs-full_OtherCurrentNonfinancialLiabilities"
                            order="50.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLiabilities" xlink:label="ifrs-full_CurrentLiabilities" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CurrentLiabilitiesAbstract"
                          xlink:to="ifrs-full_CurrentLiabilities"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="80.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-210000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAbstract" xlink:label="ifrs-full_EquityAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IssuedCapital" xlink:label="ifrs-full_IssuedCapital" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityAbstract"
                          xlink:to="ifrs-full_IssuedCapital"
                            order="10.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherReserves" xlink:label="ifrs-full_OtherReserves" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityAbstract"
                          xlink:to="ifrs-full_OtherReserves"
                            order="60.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_StatutoryReserve" xlink:label="ext_PHN_StatutoryReserve" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityAbstract"
                          xlink:to="ext_PHN_StatutoryReserve"
                            order="70.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_ReserveofRemeasurementofDefinedBenefitsPlans" xlink:label="ext_PHN_ReserveofRemeasurementofDefinedBenefitsPlans" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityAbstract"
                          xlink:to="ext_PHN_ReserveofRemeasurementofDefinedBenefitsPlans"
                            order="80.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_OCIFVReserve" xlink:label="ext_PHN_OCIFVReserve" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityAbstract"
                          xlink:to="ext_PHN_OCIFVReserve"
                            order="90.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_ReserveofExchangeDifferencesOnTranslationAndReserveOfCFHedgesMember" xlink:label="ext_PHN_ReserveofExchangeDifferencesOnTranslationAndReserveOfCFHedgesMember" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityAbstract"
                          xlink:to="ext_PHN_ReserveofExchangeDifferencesOnTranslationAndReserveOfCFHedgesMember"
                            order="100.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_ResultPeriod" xlink:label="ext_PHN_ResultPeriod" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityAbstract"
                          xlink:to="ext_PHN_ResultPeriod"
                            order="110.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityAbstract"
                          xlink:to="ifrs-full_EquityAttributableToOwnersOfParent"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="120.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityAbstract"
                          xlink:to="ifrs-full_Equity"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="140.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-210000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="ifrs-full_EquityAndLiabilitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAbstract" xlink:label="ifrs-full_EquityAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityAndLiabilitiesAbstract"
                          xlink:to="ifrs-full_EquityAbstract"
                            order="10.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="ifrs-full_LiabilitiesAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityAndLiabilitiesAbstract"
                          xlink:to="ifrs-full_LiabilitiesAbstract"
                            order="20.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAndLiabilities" xlink:label="ifrs-full_EquityAndLiabilities" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityAndLiabilitiesAbstract"
                          xlink:to="ifrs-full_EquityAndLiabilities"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="30.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-210000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_LiabilitiesAbstract" xlink:label="ifrs-full_LiabilitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_LiabilitiesAbstract"
                          xlink:to="ifrs-full_NoncurrentLiabilitiesAbstract"
                            order="10.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CurrentLiabilitiesAbstract" xlink:label="ifrs-full_CurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_LiabilitiesAbstract"
                          xlink:to="ifrs-full_CurrentLiabilitiesAbstract"
                            order="20.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-210000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentLiabilitiesAbstract" xlink:label="ifrs-full_NoncurrentLiabilitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentProvisionsAbstract" xlink:label="ifrs-full_NoncurrentProvisionsAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract"
                          xlink:to="ifrs-full_NoncurrentProvisionsAbstract"
                            order="10.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:label="ifrs-full_OtherNoncurrentFinancialLiabilities" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract"
                          xlink:to="ifrs-full_OtherNoncurrentFinancialLiabilities"
                            order="50.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentLiabilities" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_NoncurrentLiabilitiesAbstract"
                          xlink:to="ifrs-full_NoncurrentLiabilities"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="70.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-210000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentProvisionsAbstract" xlink:label="ifrs-full_NoncurrentProvisionsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:label="ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_NoncurrentProvisionsAbstract"
                          xlink:to="ifrs-full_NoncurrentProvisionsForEmployeeBenefits"
                            order="10.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherLongtermProvisions" xlink:label="ifrs-full_OtherLongtermProvisions" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_NoncurrentProvisionsAbstract"
                          xlink:to="ifrs-full_OtherLongtermProvisions"
                            order="20.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-210000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AssetsAbstract" xlink:label="ifrs-full_AssetsAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfFinancialPositionAbstract"
                          xlink:to="ifrs-full_AssetsAbstract"
                            order="20.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="ifrs-full_EquityAndLiabilitiesAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfFinancialPositionAbstract"
                          xlink:to="ifrs-full_EquityAndLiabilitiesAbstract"
                            order="30.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <!-- http://www.xbrl.org/2003/arcrole/parent-child https://www.pharmanutra.it/xbrl/role/all/ias_1_role-220000 -->
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-220000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AssetsAbstract" xlink:label="ifrs-full_AssetsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PropertyPlantAndEquipment" xlink:label="ifrs-full_PropertyPlantAndEquipment" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_AssetsAbstract"
                          xlink:to="ifrs-full_PropertyPlantAndEquipment"
                            order="10.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_AssetsAbstract"
                          xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill"
                            order="40.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:label="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_AssetsAbstract"
                          xlink:to="ifrs-full_InvestmentsInSubsidiariesJointVenturesAndAssociates"
                            order="100.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DeferredTaxAssets" xlink:label="ifrs-full_DeferredTaxAssets" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_AssetsAbstract"
                          xlink:to="ifrs-full_DeferredTaxAssets"
                            order="150.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_AssetsAbstract"
                          xlink:to="ifrs-full_CashAndCashEquivalents"
                            order="170.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Assets" xlink:label="ifrs-full_Assets" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_AssetsAbstract"
                          xlink:to="ifrs-full_Assets"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="190.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-220000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAbstract" xlink:label="ifrs-full_EquityAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IssuedCapital" xlink:label="ifrs-full_IssuedCapital" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityAbstract"
                          xlink:to="ifrs-full_IssuedCapital"
                            order="10.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherReserves" xlink:label="ifrs-full_OtherReserves" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityAbstract"
                          xlink:to="ifrs-full_OtherReserves"
                            order="60.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAttributableToOwnersOfParent" xlink:label="ifrs-full_EquityAttributableToOwnersOfParent" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityAbstract"
                          xlink:to="ifrs-full_EquityAttributableToOwnersOfParent"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="70.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityAbstract"
                          xlink:to="ifrs-full_Equity"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="90.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-220000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="ifrs-full_EquityAndLiabilitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAbstract" xlink:label="ifrs-full_EquityAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityAndLiabilitiesAbstract"
                          xlink:to="ifrs-full_EquityAbstract"
                            order="10.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAndLiabilities" xlink:label="ifrs-full_EquityAndLiabilities" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityAndLiabilitiesAbstract"
                          xlink:to="ifrs-full_EquityAndLiabilities"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="30.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-220000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfFinancialPositionAbstract" xlink:label="ifrs-full_StatementOfFinancialPositionAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AssetsAbstract" xlink:label="ifrs-full_AssetsAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfFinancialPositionAbstract"
                          xlink:to="ifrs-full_AssetsAbstract"
                            order="20.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAndLiabilitiesAbstract" xlink:label="ifrs-full_EquityAndLiabilitiesAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfFinancialPositionAbstract"
                          xlink:to="ifrs-full_EquityAndLiabilitiesAbstract"
                            order="30.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <!-- http://www.xbrl.org/2003/arcrole/parent-child https://www.pharmanutra.it/xbrl/role/all/ias_1_role-310000 -->
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-310000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfOrdinarySharesAxis" xlink:label="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis"
                          xlink:to="ifrs-full_OrdinarySharesMember"
                            order="10.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-310000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DilutedEarningsPerShareAbstract" xlink:label="ifrs-full_DilutedEarningsPerShareAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_DilutedEarningsPerShareAbstract"
                          xlink:to="ifrs-full_DilutedEarningsLossPerShare"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="30.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-310000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="ifrs-full_EarningsPerShareAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EarningsPerShareTable" xlink:label="ifrs-full_EarningsPerShareTable" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EarningsPerShareAbstract"
                          xlink:to="ifrs-full_EarningsPerShareTable"
                            order="10.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EarningsPerShareLineItems" xlink:label="ifrs-full_EarningsPerShareLineItems" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EarningsPerShareAbstract"
                          xlink:to="ifrs-full_EarningsPerShareLineItems"
                            order="20.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-310000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EarningsPerShareTable" xlink:label="ifrs-full_EarningsPerShareTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfOrdinarySharesAxis" xlink:label="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EarningsPerShareTable"
                          xlink:to="ifrs-full_ClassesOfOrdinarySharesAxis"
                            order="10.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-310000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EarningsPerShareLineItems" xlink:label="ifrs-full_EarningsPerShareLineItems" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DilutedEarningsPerShareAbstract" xlink:label="ifrs-full_DilutedEarningsPerShareAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EarningsPerShareLineItems"
                          xlink:to="ifrs-full_DilutedEarningsPerShareAbstract"
                            order="20.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-310000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="ifrs-full_IncomeStatementAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossAbstract" xlink:label="ifrs-full_ProfitLossAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_IncomeStatementAbstract"
                          xlink:to="ifrs-full_ProfitLossAbstract"
                            order="20.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="ifrs-full_EarningsPerShareAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_IncomeStatementAbstract"
                          xlink:to="ifrs-full_EarningsPerShareAbstract"
                            order="21.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-310000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossAbstract" xlink:label="ifrs-full_ProfitLossAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherIncome" xlink:label="ifrs-full_OtherIncome" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ifrs-full_OtherIncome"
                            order="90.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Revenue" xlink:label="ifrs-full_Revenue" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ifrs-full_Revenue"
                            order="100.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_Revenue" xlink:label="ext_PHN_Revenue" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ext_PHN_Revenue"
                            order="110.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ifrs-full_ProfitLossFromOperatingActivities"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="120.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceIncome" xlink:label="ifrs-full_FinanceIncome" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ifrs-full_FinanceIncome"
                            order="160.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceCosts" xlink:label="ifrs-full_FinanceCosts" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ifrs-full_FinanceCosts"
                            preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"
                            order="170.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_OperResult" xlink:label="ext_PHN_OperResult" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ext_PHN_OperResult"
                            order="270.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_DepWrOff" xlink:label="ext_PHN_DepWrOff" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ext_PHN_DepWrOff"
                            order="280.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_FinancialResults" xlink:label="ext_PHN_FinancialResults" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ext_PHN_FinancialResults"
                            order="290.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ifrs-full_ProfitLossBeforeTax"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="300.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations"
                            preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"
                            order="310.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="ifrs-full_ProfitLossFromContinuingOperations" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ifrs-full_ProfitLossFromContinuingOperations"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="320.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ifrs-full_ProfitLoss"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="340.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <!-- http://www.xbrl.org/2003/arcrole/parent-child https://www.pharmanutra.it/xbrl/role/all/ias_1_role-320000 -->
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-320000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfOrdinarySharesAxis" xlink:label="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OrdinarySharesMember" xlink:label="ifrs-full_OrdinarySharesMember" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ClassesOfOrdinarySharesAxis"
                          xlink:to="ifrs-full_OrdinarySharesMember"
                            order="10.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-320000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DilutedEarningsPerShareAbstract" xlink:label="ifrs-full_DilutedEarningsPerShareAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DilutedEarningsLossPerShare" xlink:label="ifrs-full_DilutedEarningsLossPerShare" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_DilutedEarningsPerShareAbstract"
                          xlink:to="ifrs-full_DilutedEarningsLossPerShare"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="30.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-320000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="ifrs-full_EarningsPerShareAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EarningsPerShareTable" xlink:label="ifrs-full_EarningsPerShareTable" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EarningsPerShareAbstract"
                          xlink:to="ifrs-full_EarningsPerShareTable"
                            order="10.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EarningsPerShareLineItems" xlink:label="ifrs-full_EarningsPerShareLineItems" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EarningsPerShareAbstract"
                          xlink:to="ifrs-full_EarningsPerShareLineItems"
                            order="20.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-320000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EarningsPerShareTable" xlink:label="ifrs-full_EarningsPerShareTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ClassesOfOrdinarySharesAxis" xlink:label="ifrs-full_ClassesOfOrdinarySharesAxis" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EarningsPerShareTable"
                          xlink:to="ifrs-full_ClassesOfOrdinarySharesAxis"
                            order="10.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-320000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EarningsPerShareLineItems" xlink:label="ifrs-full_EarningsPerShareLineItems" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DilutedEarningsPerShareAbstract" xlink:label="ifrs-full_DilutedEarningsPerShareAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EarningsPerShareLineItems"
                          xlink:to="ifrs-full_DilutedEarningsPerShareAbstract"
                            order="20.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-320000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeStatementAbstract" xlink:label="ifrs-full_IncomeStatementAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossAbstract" xlink:label="ifrs-full_ProfitLossAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_IncomeStatementAbstract"
                          xlink:to="ifrs-full_ProfitLossAbstract"
                            order="20.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EarningsPerShareAbstract" xlink:label="ifrs-full_EarningsPerShareAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_IncomeStatementAbstract"
                          xlink:to="ifrs-full_EarningsPerShareAbstract"
                            order="21.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-320000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossAbstract" xlink:label="ifrs-full_ProfitLossAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Revenue" xlink:label="ifrs-full_Revenue" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ifrs-full_Revenue"
                            order="10.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherIncome" xlink:label="ifrs-full_OtherIncome" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ifrs-full_OtherIncome"
                            order="20.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ChangesInInventoriesOfFinishedGoodsAndWorkInProgress" xlink:label="ifrs-full_ChangesInInventoriesOfFinishedGoodsAndWorkInProgress" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ifrs-full_ChangesInInventoriesOfFinishedGoodsAndWorkInProgress"
                            preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"
                            order="30.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RawMaterialsAndConsumablesUsed" xlink:label="ifrs-full_RawMaterialsAndConsumablesUsed" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ifrs-full_RawMaterialsAndConsumablesUsed"
                            preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"
                            order="50.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EmployeeBenefitsExpense" xlink:label="ifrs-full_EmployeeBenefitsExpense" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ifrs-full_EmployeeBenefitsExpense"
                            preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"
                            order="60.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherExpenseByNature" xlink:label="ifrs-full_OtherExpenseByNature" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ifrs-full_OtherExpenseByNature"
                            preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"
                            order="90.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ServicesExpense" xlink:label="ifrs-full_ServicesExpense" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ifrs-full_ServicesExpense"
                            order="130.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_OperativeCosts" xlink:label="ext_PHN_OperativeCosts" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ext_PHN_OperativeCosts"
                            order="140.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossFromOperatingActivities" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ifrs-full_ProfitLossFromOperatingActivities"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="150.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceIncome" xlink:label="ifrs-full_FinanceIncome" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ifrs-full_FinanceIncome"
                            order="190.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_FinanceCosts" xlink:label="ifrs-full_FinanceCosts" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ifrs-full_FinanceCosts"
                            preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"
                            order="200.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossBeforeTax" xlink:label="ifrs-full_ProfitLossBeforeTax" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ifrs-full_ProfitLossBeforeTax"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="290.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations"
                            preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"
                            order="300.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLossFromContinuingOperations" xlink:label="ifrs-full_ProfitLossFromContinuingOperations" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ifrs-full_ProfitLossFromContinuingOperations"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="310.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ProfitLossAbstract"
                          xlink:to="ifrs-full_ProfitLoss"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="330.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <!-- http://www.xbrl.org/2003/arcrole/parent-child https://www.pharmanutra.it/xbrl/role/all/ias_1_role-410000 -->
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-410000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherComprehensiveIncomeAbstract" xlink:label="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:label="ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_OtherComprehensiveIncomeAbstract"
                          xlink:to="ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="30.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-410000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:label="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract"
                          xlink:to="ifrs-full_ProfitLoss"
                            order="20.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherComprehensiveIncomeAbstract" xlink:label="ifrs-full_OtherComprehensiveIncomeAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract"
                          xlink:to="ifrs-full_OtherComprehensiveIncomeAbstract"
                            order="30.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ifrs-full_ComprehensiveIncome" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract"
                          xlink:to="ifrs-full_ComprehensiveIncome"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="40.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <!-- http://www.xbrl.org/2003/arcrole/parent-child https://www.pharmanutra.it/xbrl/role/all/ias_1_role-420000 -->
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-420000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:label="ifrs-full_StatementOfComprehensiveIncomeAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract"
                          xlink:to="ifrs-full_ProfitLoss"
                            order="20.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ifrs-full_ComprehensiveIncome" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfComprehensiveIncomeAbstract"
                          xlink:to="ifrs-full_ComprehensiveIncome"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="40.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <!-- http://www.xbrl.org/2003/arcrole/parent-child https://www.pharmanutra.it/xbrl/role/all/ias_1_role-610000 -->
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-610000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ChangesInEquityAbstract" xlink:label="ifrs-full_ChangesInEquityAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncomeAbstract" xlink:label="ifrs-full_ComprehensiveIncomeAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ChangesInEquityAbstract"
                          xlink:to="ifrs-full_ComprehensiveIncomeAbstract"
                            order="10.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_DestResult" xlink:label="ext_PHN_DestResult" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ChangesInEquityAbstract"
                          xlink:to="ext_PHN_DestResult"
                            order="60.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity" xlink:label="ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ChangesInEquityAbstract"
                          xlink:to="ifrs-full_IncreaseDecreaseThroughTransfersAndOtherChangesEquity"
                            order="70.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_DivDistrib" xlink:label="ext_PHN_DivDistrib" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ChangesInEquityAbstract"
                          xlink:to="ext_PHN_DivDistrib"
                            order="150.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-610000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncomeAbstract" xlink:label="ifrs-full_ComprehensiveIncomeAbstract" xlink:type="locator"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_PL" xlink:label="ext_PHN_PL" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ComprehensiveIncomeAbstract"
                          xlink:to="ext_PHN_PL"
                            order="10.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ComprehensiveIncomeAbstract"
                          xlink:to="ifrs-full_ProfitLoss"
                            order="20.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:label="ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ComprehensiveIncomeAbstract"
                          xlink:to="ifrs-full_OtherComprehensiveIncomeThatWillNotBeReclassifiedToProfitOrLossNetOfTax"
                            order="40.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComprehensiveIncome" xlink:label="ifrs-full_ComprehensiveIncome" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ComprehensiveIncomeAbstract"
                          xlink:to="ifrs-full_ComprehensiveIncome"
                            preferredLabel="http://www.xbrl.org/2003/role/totalLabel"
                            order="50.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-610000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityMember" xlink:label="ifrs-full_EquityMember" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ComponentsOfEquityAxis"
                          xlink:to="ifrs-full_EquityMember"
                            order="10.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-610000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityMember" xlink:label="ifrs-full_EquityMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityMember"
                          xlink:to="ifrs-full_EquityAttributableToOwnersOfParentMember"
                            order="10.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_PeriodResult" xlink:label="ext_PHN_PeriodResult" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityMember"
                          xlink:to="ext_PHN_PeriodResult"
                            order="30.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_StatReserve" xlink:label="ext_PHN_StatReserve" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityMember"
                          xlink:to="ext_PHN_StatReserve"
                            order="40.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_ResofRemeasurementofDefinedBenefitsPlans" xlink:label="ext_PHN_ResofRemeasurementofDefinedBenefitsPlans" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityMember"
                          xlink:to="ext_PHN_ResofRemeasurementofDefinedBenefitsPlans"
                            order="50.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_ResofExchangeDifferencesOnTranslationAndReserveOfCFHedgesMember" xlink:label="ext_PHN_ResofExchangeDifferencesOnTranslationAndReserveOfCFHedgesMember" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityMember"
                          xlink:to="ext_PHN_ResofExchangeDifferencesOnTranslationAndReserveOfCFHedgesMember"
                            order="60.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-610000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:label="ifrs-full_EquityAttributableToOwnersOfParentMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IssuedCapitalMember" xlink:label="ifrs-full_IssuedCapitalMember" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityAttributableToOwnersOfParentMember"
                          xlink:to="ifrs-full_IssuedCapitalMember"
                            order="10.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherReservesMember" xlink:label="ifrs-full_OtherReservesMember" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_EquityAttributableToOwnersOfParentMember"
                          xlink:to="ifrs-full_OtherReservesMember"
                            order="50.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-610000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherReservesMember" xlink:label="ifrs-full_OtherReservesMember" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ReserveOfChangeInValueOfTimeValueOfOptionsMember" xlink:label="ifrs-full_ReserveOfChangeInValueOfTimeValueOfOptionsMember" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_OtherReservesMember"
                          xlink:to="ifrs-full_ReserveOfChangeInValueOfTimeValueOfOptionsMember"
                            order="50.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-610000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RestatedMember" xlink:label="ifrs-full_RestatedMember" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis"
                          xlink:to="ifrs-full_RestatedMember"
                            order="10.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-610000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfChangesInEquityAbstract" xlink:label="ifrs-full_StatementOfChangesInEquityAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="ifrs-full_StatementOfChangesInEquityTable" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfChangesInEquityAbstract"
                          xlink:to="ifrs-full_StatementOfChangesInEquityTable"
                            order="20.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfChangesInEquityAbstract"
                          xlink:to="ifrs-full_StatementOfChangesInEquityLineItems"
                            order="30.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-610000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfChangesInEquityTable" xlink:label="ifrs-full_StatementOfChangesInEquityTable" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ComponentsOfEquityAxis" xlink:label="ifrs-full_ComponentsOfEquityAxis" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfChangesInEquityTable"
                          xlink:to="ifrs-full_ComponentsOfEquityAxis"
                            order="10.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:label="ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfChangesInEquityTable"
                          xlink:to="ifrs-full_RetrospectiveApplicationAndRetrospectiveRestatementAxis"
                            order="20.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_1_role-610000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfChangesInEquityLineItems" xlink:label="ifrs-full_StatementOfChangesInEquityLineItems" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfChangesInEquityLineItems"
                          xlink:to="ifrs-full_Equity"
                            preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"
                            order="10.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ChangesInEquityAbstract" xlink:label="ifrs-full_ChangesInEquityAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfChangesInEquityLineItems"
                          xlink:to="ifrs-full_ChangesInEquityAbstract"
                            order="20.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_Equity" xlink:label="ifrs-full_Equity_2" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfChangesInEquityLineItems"
                          xlink:to="ifrs-full_Equity_2"
                            preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"
                            order="30.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <!-- http://www.xbrl.org/2003/arcrole/parent-child https://www.pharmanutra.it/xbrl/role/all/ias_26_role-710000 -->
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_26_role-710000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ChangesInNetAssetsAvailableForBenefitsAbstract" xlink:label="ifrs-full_ChangesInNetAssetsAvailableForBenefitsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_OtherIncome" xlink:label="ifrs-full_OtherIncome" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ChangesInNetAssetsAvailableForBenefitsAbstract"
                          xlink:to="ifrs-full_OtherIncome"
                            order="40.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ChangesInNetAssetsAvailableForBenefitsAbstract"
                          xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations"
                            preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"
                            order="80.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_26_role-710000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ReconciliationOfChangesInNetAssetsAvailableForBenefitsAbstract" xlink:label="ifrs-full_ReconciliationOfChangesInNetAssetsAvailableForBenefitsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ChangesInNetAssetsAvailableForBenefitsAbstract" xlink:label="ifrs-full_ChangesInNetAssetsAvailableForBenefitsAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_ReconciliationOfChangesInNetAssetsAvailableForBenefitsAbstract"
                          xlink:to="ifrs-full_ChangesInNetAssetsAvailableForBenefitsAbstract"
                            order="20.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_26_role-710000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfChangesInNetAssetsAvailableForBenefitsAbstract" xlink:label="ifrs-full_StatementOfChangesInNetAssetsAvailableForBenefitsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ReconciliationOfChangesInNetAssetsAvailableForBenefitsAbstract" xlink:label="ifrs-full_ReconciliationOfChangesInNetAssetsAvailableForBenefitsAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfChangesInNetAssetsAvailableForBenefitsAbstract"
                          xlink:to="ifrs-full_ReconciliationOfChangesInNetAssetsAvailableForBenefitsAbstract"
                            order="60.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <!-- http://www.xbrl.org/2003/arcrole/parent-child https://www.pharmanutra.it/xbrl/role/all/ias_7_role-510000 -->
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_7_role-510000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DividendsPaidClassifiedAsFinancingActivities" xlink:label="ifrs-full_DividendsPaidClassifiedAsFinancingActivities" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"
                          xlink:to="ifrs-full_DividendsPaidClassifiedAsFinancingActivities"
                            preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"
                            order="110.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"
                          xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities"
                            preferredLabel="http://www.xbrl.org/2009/role/netLabel"
                            order="150.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_7_role-510000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"
                          xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"
                            preferredLabel="http://www.xbrl.org/2003/role/terseLabel"
                            order="70.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"
                          xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"
                            preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"
                            order="80.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsInvestingActivities" xlink:label="ifrs-full_IncomeTaxesPaidRefundClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"
                          xlink:to="ifrs-full_IncomeTaxesPaidRefundClassifiedAsInvestingActivities"
                            preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"
                            order="210.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"
                          xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities"
                            preferredLabel="http://www.xbrl.org/2009/role/netLabel"
                            order="230.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_7_role-510000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract"
                          xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities"
                            preferredLabel="http://www.xbrl.org/2009/role/netLabel"
                            order="100.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_7_role-510000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfCashFlowsAbstract"
                          xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract"
                            order="20.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfCashFlowsAbstract"
                          xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"
                            order="30.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfCashFlowsAbstract"
                          xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"
                            order="40.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfCashFlowsAbstract"
                          xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges"
                            preferredLabel="http://www.xbrl.org/2009/role/netLabel"
                            order="50.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHNChangeCash" xlink:label="ext_PHNChangeCash" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfCashFlowsAbstract"
                          xlink:to="ext_PHNChangeCash"
                            order="70.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfCashFlowsAbstract"
                          xlink:to="ifrs-full_CashAndCashEquivalents"
                            preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"
                            order="90.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents_2" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfCashFlowsAbstract"
                          xlink:to="ifrs-full_CashAndCashEquivalents_2"
                            preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"
                            order="110.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <!-- http://www.xbrl.org/2003/arcrole/parent-child https://www.pharmanutra.it/xbrl/role/all/ias_7_role-520000 -->
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_7_role-520000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract"
                          xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInInventories"
                            order="30.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract"
                          xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"
                            order="40.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract"
                          xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables"
                            order="50.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract"
                          xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable"
                            order="60.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherOperatingPayables" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherOperatingPayables" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract"
                          xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherOperatingPayables"
                            order="70.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract"
                          xlink:to="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense"
                            order="80.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForProvisions" xlink:label="ifrs-full_AdjustmentsForProvisions" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract"
                          xlink:to="ifrs-full_AdjustmentsForProvisions"
                            order="100.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_ChangeTaxRec" xlink:label="ext_PHN_ChangeTaxRec" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract"
                          xlink:to="ext_PHN_ChangeTaxRec"
                            order="190.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_ChangeInRiskFounds" xlink:label="ext_PHN_ChangeInRiskFounds" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract"
                          xlink:to="ext_PHN_ChangeInRiskFounds"
                            order="210.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_ChangeInEmployeesBenefits" xlink:label="ext_PHN_ChangeInEmployeesBenefits" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract"
                          xlink:to="ext_PHN_ChangeInEmployeesBenefits"
                            order="220.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_ChangeTaxPayable" xlink:label="ext_PHN_ChangeTaxPayable" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_AdjustmentsForReconcileProfitLossAbstract"
                          xlink:to="ext_PHN_ChangeTaxPayable"
                            order="230.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_7_role-520000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_DividendsPaidClassifiedAsFinancingActivities" xlink:label="ifrs-full_DividendsPaidClassifiedAsFinancingActivities" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"
                          xlink:to="ifrs-full_DividendsPaidClassifiedAsFinancingActivities"
                            preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"
                            order="110.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_IncrCurrFinAss" xlink:label="ext_PHN_IncrCurrFinAss" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"
                          xlink:to="ext_PHN_IncrCurrFinAss"
                            order="160.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_DecrCurrFinAss" xlink:label="ext_PHN_DecrCurrFinAss" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"
                          xlink:to="ext_PHN_DecrCurrFinAss"
                            order="170.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_IncrCurrFinLiab" xlink:label="ext_PHN_IncrCurrFinLiab" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"
                          xlink:to="ext_PHN_IncrCurrFinLiab"
                            order="180.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_DecCurrFinLiab" xlink:label="ext_PHN_DecCurrFinLiab" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"
                          xlink:to="ext_PHN_DecCurrFinLiab"
                            order="190.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHNChangesinnetassestsavailableforbenefits" xlink:label="ext_PHNChangesinnetassestsavailableforbenefits" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"
                          xlink:to="ext_PHNChangesinnetassestsavailableforbenefits"
                            order="210.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_IncrNCFinAss" xlink:label="ext_PHN_IncrNCFinAss" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"
                          xlink:to="ext_PHN_IncrNCFinAss"
                            order="220.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_IncrNCFinLiab" xlink:label="ext_PHN_IncrNCFinLiab" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"
                          xlink:to="ext_PHN_IncrNCFinLiab"
                            order="240.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_DecNCurrFinLiab" xlink:label="ext_PHN_DecNCurrFinLiab" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"
                          xlink:to="ext_PHN_DecNCurrFinLiab"
                            order="250.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"
                          xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities"
                            preferredLabel="http://www.xbrl.org/2009/role/netLabel"
                            order="260.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_7_role-520000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"
                          xlink:to="ifrs-full_ProceedsFromSalesOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"
                            preferredLabel="http://www.xbrl.org/2003/role/terseLabel"
                            order="70.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"
                          xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"
                            preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"
                            order="80.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncomeTaxesPaidRefundClassifiedAsInvestingActivities" xlink:label="ifrs-full_IncomeTaxesPaidRefundClassifiedAsInvestingActivities" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"
                          xlink:to="ifrs-full_IncomeTaxesPaidRefundClassifiedAsInvestingActivities"
                            preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"
                            order="210.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_TFMCredit" xlink:label="ext_PHN_TFMCredit" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"
                          xlink:to="ext_PHN_TFMCredit"
                            order="230.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="815600F8217BC7733697-2021-12-31.xsd#ext_PHN_IncrFinAssets" xlink:label="ext_PHN_IncrFinAssets" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"
                          xlink:to="ext_PHN_IncrFinAssets"
                            order="250.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"
                          xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities"
                            preferredLabel="http://www.xbrl.org/2009/role/netLabel"
                            order="260.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_7_role-520000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_ProfitLoss" xlink:label="ifrs-full_ProfitLoss" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract"
                          xlink:to="ifrs-full_ProfitLoss"
                            order="10.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:label="ifrs-full_AdjustmentsForReconcileProfitLossAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract"
                          xlink:to="ifrs-full_AdjustmentsForReconcileProfitLossAbstract"
                            order="20.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract"
                          xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities"
                            preferredLabel="http://www.xbrl.org/2009/role/netLabel"
                            order="100.0"
                          xlink:type="arc"/>
   </link:presentationLink>
   <link:presentationLink xlink:role="https://www.pharmanutra.it/xbrl/role/all/ias_7_role-520000" xlink:type="extended">
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_StatementOfCashFlowsAbstract" xlink:label="ifrs-full_StatementOfCashFlowsAbstract" xlink:type="locator"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfCashFlowsAbstract"
                          xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivitiesAbstract"
                            order="20.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfCashFlowsAbstract"
                          xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivitiesAbstract"
                            order="30.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfCashFlowsAbstract"
                          xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivitiesAbstract"
                            order="40.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfCashFlowsAbstract"
                          xlink:to="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges"
                            preferredLabel="http://www.xbrl.org/2009/role/netLabel"
                            order="50.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfCashFlowsAbstract"
                          xlink:to="ifrs-full_CashAndCashEquivalents"
                            preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"
                            order="80.0"
                          xlink:type="arc"/>
      <link:loc xlink:href="http://xbrl.ifrs.org/taxonomy/2020-03-16/full_ifrs/full_ifrs-cor_2020-03-16.xsd#ifrs-full_CashAndCashEquivalents" xlink:label="ifrs-full_CashAndCashEquivalents_2" xlink:type="locator"/>
      <link:presentationArc
                          xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child"
                          xlink:from="ifrs-full_StatementOfCashFlowsAbstract"
                          xlink:to="ifrs-full_CashAndCashEquivalents_2"
                            preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"
                            order="90.0"
                          xlink:type="arc"/>
   </link:presentationLink>

</link:linkbase>